CN Patent

CN115916154A — 包括氘代丁苯那嗪的渗透剂型及其使用方法

Assigned to Ospex Pharmaceuticals · Expires 2023-04-04 · 3y expired

What this patent protects

本文提供了用于治疗例如运动增多性运动障碍的含有氘代丁苯那嗪的渗透剂型。当向受试者每日一次口服施用时，所述剂型为所述活性剂提供了有利的药代动力学特征，表明在延长的时间段内具有治疗功效。

USPTO Abstract

本文提供了用于治疗例如运动增多性运动障碍的含有氘代丁苯那嗪的渗透剂型。当向受试者每日一次口服施用时，所述剂型为所述活性剂提供了有利的药代动力学特征，表明在延长的时间段内具有治疗功效。

Drugs covered by this patent

Patent Metadata

Patent number
CN115916154A
Jurisdiction
CN
Classification
—
Expires
2023-04-04
Drug substance claim
No
Drug product claim
No
Assignee
Ospex Pharmaceuticals
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.